Holen Sie sich die Stockscreener-App
103.70
5.32%
-5.83
Schlusskurs vom Vortag:
$109.53
Offen:
$102
24-Stunden-Volumen:
253.86K
Relative Volume:
3.97
Marktkapitalisierung:
$4.71B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.91%
1M Leistung:
+1.44%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$97.56
$107.00
1-Wochen-Bereich:
$97.56
$118.00
52-Wochen-Spanne:
$88.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Firmenname
Billiontoone Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BLLN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
103.70 | 4.97B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | BTIG Research | Buy |
| 2025-12-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-12-01 | Eingeleitet | Jefferies | Hold |
| 2025-12-01 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Eingeleitet | Stifel | Buy |
| 2025-12-01 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-12-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Billiontoone Inc Aktie (BLLN) Neueste Nachrichten
BillionToOne, Inc. SEC 10-Q Report - TradingView
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com India
BillionToOne price target lowered to $145 from $150 at JPMorgan - TipRanks
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks
BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com India
BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView
BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks
(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com
(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com
BillionToOne Reports Third Quarter 2025 Results - The Manila Times
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - PR Newswire
Is BillionToOne’s Triple Digit Share Price Justified After Recent Volatility and Growth Hopes? - Yahoo Finance
Reassessing BillionToOne (BLLN) Valuation After a Recent Share Price Rebound - Yahoo Finance
BillionToOne initiated with an Overweight at JPMorgan - MSN
BillionToOne2025 Funding Rounds & List of Investors - Tracxn
BillionToOne, Inc.: Target Price Consensus and Analysts Recommendations | BLLN | US0901681058 - marketscreener.com
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - MSN
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne initiated with a Hold at Jefferies - MSN
BillionToOne initiated with an Overweight at Piper Sandler - MSN
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
BillionToOne (NASDAQ: BLLN) schedules Q3 2025 results and call for Dec. 9, 2025 - Stock Titan
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com Australia
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne initiated with an Equal Weight at Wells Fargo - MSN
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates BillionToOne at Hold With $117 Price Target - marketscreener.com
Stifel Initiates BillionToOne at Buy With $145 Price Target - marketscreener.com
Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
JPMorgan Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
Finanzdaten der Billiontoone Inc-Aktie (BLLN)
Es liegen keine Finanzdaten für Billiontoone Inc (BLLN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):